475 related articles for article (PubMed ID: 27788026)
1. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.
Powers SW; Coffey CS; Chamberlin LA; Ecklund DJ; Klingner EA; Yankey JW; Korbee LL; Porter LL; Hershey AD;
N Engl J Med; 2017 Jan; 376(2):115-124. PubMed ID: 27788026
[TBL] [Abstract][Full Text] [Related]
2. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
5. Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.
Hershey AD; Powers SW; Coffey CS; Eklund DD; Chamberlin LA; Korbee LL;
Headache; 2013 May; 53(5):799-816. PubMed ID: 23594025
[TBL] [Abstract][Full Text] [Related]
6. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
7. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
8. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
9. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
Keskinbora K; Aydinli I
Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
Storey JR; Calder CS; Hart DE; Potter DL
Headache; 2001; 41(10):968-75. PubMed ID: 11903524
[TBL] [Abstract][Full Text] [Related]
11. Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments.
Gibler RC; Peugh JL; Coffey CS; Chamberlin LA; Ecklund D; Klingner E; Yankey J; Korbee LL; Kabbouche M; Kacperski J; Porter LL; Reidy BL; Hershey AD; Powers SW
Headache; 2023 Jun; 63(6):805-812. PubMed ID: 36757131
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Lewis D; Winner P; Saper J; Ness S; Polverejan E; Wang S; Kurland CL; Nye J; Yuen E; Eerdekens M; Ford L
Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
[TBL] [Abstract][Full Text] [Related]
13. Time course of adverse events most commonly associated with topiramate for migraine prevention.
Láinez MJ; Freitag FG; Pfeil J; Ascher S; Olson WH; Schwalen S
Eur J Neurol; 2007 Aug; 14(8):900-6. PubMed ID: 17662012
[TBL] [Abstract][Full Text] [Related]
14. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
15. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing amitriptyline versus topiramate for the prophylaxis of chronic daily headache in pediatric patients.
Sezer T; Kandemir H; Alehan F
Int J Neurosci; 2013 Aug; 123(8):553-6. PubMed ID: 23421731
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
He A; Song D; Zhang L; Li C
J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
[TBL] [Abstract][Full Text] [Related]
18. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.
Freitag FG; Forde G; Neto W; Wang DZ; Schmitt J; Wu SC; Hulihan J
J Am Osteopath Assoc; 2007 Jul; 107(7):251-8. PubMed ID: 17682112
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial.
Powers SW; Coffey CS; Chamberlin LA; Ecklund DJ; Klingner EA; Yankey JW; Peugh JL; Korbee LL; Simmons K; Sullivan SM; Kabbouche MA; Kacperski J; Porter LL; Reidy BL; Hershey AD
JAMA Netw Open; 2021 Jul; 4(7):e2114712. PubMed ID: 34251445
[TBL] [Abstract][Full Text] [Related]
20. Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
Reidy BL; Peugh J; Hershey AD; Coffey CS; Chamberlin LA; Ecklund DJ; Klingner EA; Yankey JW; Korbee LL; Porter LL; Kabbouche MA; Kacperski J; Powers SW
Cephalalgia; 2022 Jan; 42(1):44-52. PubMed ID: 34404270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
